Literature DB >> 10534660

Glipizide-induced pigmented purpuric dermatosis.

B B Adams1, A S Gadenne.   

Abstract

Pigmented purpuric dermatosis can occasionally be caused by various medications. No reported cases of oral hypoglycemic agents causing pigmented purpuric dermatosis exist. We report a case of glipizide-induced pigmented dermatosis.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10534660     DOI： 10.1016/s0190-9622(99)70335-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


  6 in total

1.  Characteristics and Clinical Manifestations of Pigmented Purpuric Dermatosis.

Authors:  Dai Hyun Kim; Soo Hong Seo; Hyo Hyun Ahn; Young Chul Kye; Jae Eun Choi
Journal:  Ann Dermatol       Date:  2015-07-29       Impact factor: 1.444

2.  [Bufexamac-induced pigmented purpuric eruption].

Authors:  K Waltermann; W Ch Marsch; B Kreft
Journal:  Hautarzt       Date:  2009-05       Impact factor: 0.751

3.  Clinical applications of drug desensitization in the Asia-Pacific region.

Authors:  Bernard Yu-Hor Thong
Journal:  Asia Pac Allergy       Date:  2011-04-26

4.  Dermoscopic Findings and the Clinicopathologic Correlation of Pigmented Purpuric Dermatosis: A Retrospective Review of 60 Cases.

Authors:  Ko Eun Kim; Hye-Rim Moon; Hwa Jung Ryu
Journal:  Ann Dermatol       Date:  2021-05-04       Impact factor: 1.444

Review 5.  Pigmented Purpuric Dermatoses: A Complete Narrative Review.

Authors:  Cristina B Spigariolo; Serena Giacalone; Gianluca Nazzaro
Journal:  J Clin Med       Date:  2021-05-25       Impact factor: 4.241

6.  Clinicoepidemiological study of pigmented purpuric dermatoses.

Authors:  Lata Sharma; S Gupta
Journal:  Indian Dermatol Online J       Date:  2012-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.